Home
Novavax NVAX spent $140K on lobbying in Q1 2026 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $140,000
- Quarter
- Q1 2026
- Stock
- Novavax NVAX
- Client
- Novavax
- Reported
- 26/04/20
Up 27.3% from last quarter
What else happened in Novavax around then
Filed or reported within 30 days of the trade day · 03/01~04/30Novavax's other lobbying reports
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$130K
$130K
Reported 07/17
for Q2
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$50K
$50K
Reported 07/16
for Q2
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$50K
$50K
Reported 07/15
for Q2
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$50K
$50K
Reported 04/16
for Q1
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$50K
$50K
Reported 04/15
for Q1